Leading the Way in Life Science Technologies

GEN Exclusives

More »

February 15, Vol. 34, No. 4

  • Columns

    • Tonix Targets Reformulation to Create Value
    • Gail Dutton
    • Tonix Pharmaceuticals is staking out its territory in drug reformulations Drug reformulation enables pharma companies to maximize the value of existing drugs, and also provides an alternative to an orphan drug development strategy for companies seeking an early revenue stream... more »
    • Seizing Immunoassay Opportunities
    • Bruce Carlson
    • At first glance, the immunoassay market would seem to offer little to healthcare marketers or investors seeking high revenue growth opportunities Immunoassays are, frankly, an older category of tests The first tests were launched in the 1960s Some of the ... more »